These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19674285)

  • 21. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
    Kamal SM; Kassim SK; Ahmed AI; Mahmoud S; Bahnasy KA; Hafez TA; Aziz IA; Fathelbab IF; Mansour HM
    Am J Gastroenterol; 2014 Feb; 109(2):199-211. PubMed ID: 24445571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute hepatitis C in Spain: a retrospective study of 131 cases.
    Pérez-Álvarez R; García-Samaniego J; Solá R; Pérez-López R; Bárcena R; Planas R; Cañete N; Manzano ML; Gutiérrez ML; Morano L; Rodrigo L
    Rev Esp Enferm Dig; 2012 Feb; 104(1):21-8. PubMed ID: 22300113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
    Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
    Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients.
    Devaki P; Jencks D; Yee BE; Nguyen MH
    Hepatol Int; 2015 Jul; 9(3):431-7. PubMed ID: 26016464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
    Martin MT; Deming P
    Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.
    Dintsios CM; Haverkamp A; Wiegand J; Gerlach T; Wedemeyer H; Pape G; Manns MP; Krauth C
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):278-88. PubMed ID: 19550347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review and meta-analysis of HCV clearance.
    Gauthiez E; Habfast-Robertson I; Rüeger S; Kutalik Z; Aubert V; Berg T; Cerny A; Gorgievski M; George J; Heim MH; Malinverni R; Moradpour D; Müllhaupt B; Negro F; Semela D; Semmo N; Villard J; Bibert S; Bochud PY;
    Liver Int; 2017 Oct; 37(10):1431-1445. PubMed ID: 28261910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.
    Steininger K; Boyd A; Dupke S; Krznaric I; Carganico A; Munteanu M; Neifer S; Schuetze M; Obermeier M; Arasteh K; Baumgarten A; Ingiliz P
    J Viral Hepat; 2017 Oct; 24(10):832-839. PubMed ID: 28439936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection.
    Sikavi C; Najarian L; Saab S
    Dig Dis Sci; 2018 Nov; 63(11):2829-2839. PubMed ID: 30094623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon therapy for acute hepatitis C viral infection--a review by meta-analysis.
    Quin JW
    Aust N Z J Med; 1997 Oct; 27(5):611-7; discussion 617-8. PubMed ID: 9404604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection.
    McGovern BH; Nagami EH; Birch CE; Bowen MJ; Reyor LL; Chung RT; Kim AY
    J Infect Dis; 2009 Sep; 200(6):877-81. PubMed ID: 19673649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and ribavirin.
    Webster DP; Wojcikiewicz T; Keller M; Castelnovo D; Mistry H; Gilleece Y; Tibble J; Fisher M
    Int J STD AIDS; 2013 Mar; 24(3):179-83. PubMed ID: 23514835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Nahon P; Bourcier V; Layese R; Audureau E; Cagnot C; Marcellin P; Guyader D; Fontaine H; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Leroy V; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Dharancy S; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Zucman D; Di Martino V; Thibaut V; Salmon D; Ziol M; Sutton A; Pol S; Roudot-Thoraval F;
    Gastroenterology; 2017 Jan; 152(1):142-156.e2. PubMed ID: 27641509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C.
    Li J; Gordon SC; Zhou Y; Boscarino JA; Schmidt MA; Daida YG; Rupp LB; Trudeau S; Lu M;
    Am J Gastroenterol; 2021 Mar; 116(3):576-583. PubMed ID: 33399360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.
    Sikavi C; Chen PH; Lee AD; Saab EG; Choi G; Saab S
    Hepatology; 2018 Mar; 67(3):847-857. PubMed ID: 29108121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV.
    Del Bello D; Cha A; Sorbera M; Bichoupan K; Levine C; Doyle E; Harty A; Patel N; Ng M; Gardenier D; Odin J; Schiano TD; Fierer DS; Berkowitz L; Perumalswami PV; Dieterich DT; Branch AD
    Clin Infect Dis; 2016 Jun; 62(12):1497-1504. PubMed ID: 26936665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection.
    Hashem M; Zaghla H; Zakaria Z; Allam WR; Sameea EA; Mikhail NN; Sobhy M; Galal IF; Mokhtar Y; Hamdy S; Galal G; Abdelwahab SF; Waked I
    J Med Virol; 2018 Dec; 90(12):1841-1847. PubMed ID: 30011346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.
    Harrison SA; Abdurakhmanov D; Shiffman ML; Bakulin I; Mazur W; Rodriguez-Torres M; Silva GF; Cheinquer H; Messinger D; Connell EV; McKenna M; Tatsch F; Reddy KR;
    J Clin Gastroenterol; 2013 Mar; 47(3):271-9. PubMed ID: 22951527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.